Clinical Enrollment Completed
Clinical study enrollment completed in Ecuador with outstanding sample quality and efficiency.
Limaca’s Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment
TPT status granted, expanding patient access and supporting hospital adoption
Limaca Medical Receives FDA 510(k) Clearance for Breakthrough Precision GI™ Endoscopic Biopsy Device
Limaca Medical announced today that its Precision GI™ Endoscopic Ultrasound (EUS) Biopsy Device received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”)….
Limaca Medical and HekaBio Announce Japan Partnership
Limaca Medical and HekaBio K.K. announced today that they have inked a strategic partnership agreement, whereby HekaBio is to distribute Limaca’s Precision-GI™ Endoscopic Biopsy Device in Japan…
Limaca Medical Receives FDA Breakthrough Device Designation
Limaca Medical announced today that its Precision-GI™ Endoscopic Ultrasound Biopsy Product has received a Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”).
Limaca Medical Raises $1.25 Million to Enhance Precision Medicine Through Improved Biopsies
Limaca Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel- and Singapore-based investment group focused on high-growth medical and agrifood technologies…….